KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Change in Taxes (2016 - 2025)

Edwards Lifesciences (EW) has 12 years of Change in Taxes data on record, last reported at $57.6 million in Q4 2025.

  • For Q4 2025, Change in Taxes rose 111.79% year-over-year to $57.6 million; the TTM value through Dec 2025 reached -$141.8 million, up 24.05%, while the annual FY2025 figure was -$141.8 million, 24.05% up from the prior year.
  • Change in Taxes reached $57.6 million in Q4 2025 per EW's latest filing, up from -$10.2 million in the prior quarter.
  • Across five years, Change in Taxes topped out at $671.8 million in Q3 2024 and bottomed at -$488.5 million in Q4 2024.
  • Average Change in Taxes over 5 years is -$13.9 million, with a median of -$2.2 million recorded in 2021.
  • Peak YoY movement for Change in Taxes: crashed 805.17% in 2022, then soared 792.16% in 2024.
  • A 5-year view of Change in Taxes shows it stood at $33.0 million in 2021, then plummeted by 143.64% to -$14.4 million in 2022, then crashed by 678.47% to -$112.1 million in 2023, then tumbled by 335.77% to -$488.5 million in 2024, then surged by 111.79% to $57.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Taxes were $57.6 million in Q4 2025, -$10.2 million in Q3 2025, and -$240.4 million in Q2 2025.